delta-Opioid receptor-selective drugs may provide an alternative to mu
-opioid-selective drugs currently used for the relief of pain. To deve
lop improved delta-opioid receptor-selective drugs, better measures of
drug activity are necessary. In this review we suggest that efficacy
calculations provide a superior measure of drug activity as compared t
o dissociation constants and drug potencies in functional assays. Effi
cacy, as discussed in this review, is defined as a quantitative measur
ement of the ability of a drug to stimulate second messenger systems o
r measurable functional responses in cells or tissues under standard c
onditions. Efficacy values will allow medicinal chemists to understand
the contributions of both the coupling efficiency and dissociation co
nstant to drug potencies in the development of new delta-opioid recept
or-selective drugs.